Biotin-d(PEG)2-Preladenant Conjugate

Preladenant (previously known as SCH-420814) is an antagonist for adenosine A2A receptor with high affinity (Ki of 1.1 nM in vitro) and selectivity (>1000-fold over other adenosine receptos. It was initially developed by Schering-Plough as a potential treatment for Parkinson's disease. This Biotin-d(PEG)2-Preladenant conjugate was designed with a flexible PEG linker and synthesized at CellMosaic for our customer’s usage of detecting and characterizing A2AR receptor.

The final product is supplied as a DMSO solution at 5 mg/mL.

The product is sold as 1 vial of 1 mg (Cat# CM61008-1MG), 5 vials of 1 mg (Cat# CM61008-5MG), and 10 vials of 1 mg (Cat# CM61008-10MG). For bulk orders, please contact us for a quote.

Chemical Information
• Chemical name: Biotin-d(PEG)2-Preladenant
• Chemical formula: C43H60IN13O8S
• Molecular weight: 1046 Da

Specification
• Physical appearance: light beige solution
• Storage temp.: 2-8 °C
• Purity: ≥ 94 % by HPLC
• MS Data Obtained by ESI-MS: Calculated exact mass [M]+: 918.44 Da. Obtained MS [M]+: 918.4
• Degree of Labeling (DOL): 1:1 (biotin:preladenant)

Please contact us at for specific academic pricing.